1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Arteriovenous Fistula Global Clinical Trials Review, H1, 2015

Arteriovenous Fistula Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Arteriovenous Fistula Global Clinical Trials Review, H1, 2015" provides data on the Arteriovenous Fistula clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arteriovenous Fistula. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Arteriovenous Fistula. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Arteriovenous Fistula Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Arteriovenous Fistula 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Arteriovenous Fistula 22
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Arteriovenous Fistula Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Arteriovenous Fistula 29
Apr 13, 2015: Proteon Therapeutics to Present at Two International Vascular Access Conferences 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Shire Plc 30
Clinical Trial Overview of Shire Plc 30
Proteon Therapeutics, Inc. 31
Clinical Trial Overview of Proteon Therapeutics, Inc. 31
CYATHUS EXQUIRERE Pharmaforschungs GmbH 32
Clinical Trial Overview of CYATHUS EXQUIRERE Pharmaforschungs GmbH 32
Celladon Corporation 33
Clinical Trial Overview of Celladon Corporation 33
Clinical Trial Overview of Top Institutes / Government 34
California Institute of Renal Research 34
Clinical Trial Overview of California Institute of Renal Research 34
Capital Medical University 35
Clinical Trial Overview of Capital Medical University 35
City Hospitals Sunderland NHS Foundation Trust 36
Clinical Trial Overview of City Hospitals Sunderland NHS Foundation Trust 36
Department of Health, UK 37
Clinical Trial Overview of Department of Health, UK 37
Duke University 38
Clinical Trial Overview of Duke University 38
Emory University 39
Clinical Trial Overview of Emory University 39
Englewood Hospital and Medical Center 40
Clinical Trial Overview of Englewood Hospital and Medical Center 40
Japan Interventional Radiology in Oncology Study Group 41
Clinical Trial Overview of Japan Interventional Radiology in Oncology Study Group 41
National Cheng-Kung University Hospital 42
Clinical Trial Overview of National Cheng-Kung University Hospital 42
NHS Greater Glasgow and Clyde 43
Clinical Trial Overview of NHS Greater Glasgow and Clyde 43
Five Key Clinical Profiles 44
Appendix 59
Abbreviations 59
Definitions 59
Research Methodology 60
Secondary Research 60
About GlobalData 61
Contact Us 61
Disclaimer 61
Source 61

List of Tables
Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Region, 2015* 7
Arteriovenous Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Arteriovenous Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Arteriovenous Fistula Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11
Arteriovenous Fistula Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Arteriovenous Fistula Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 14
Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 17
Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Arteriovenous Fistula Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Arteriovenous Fistula Therapeutics, Global, Withdrawn Clinical Trials, 2015* 22
Arteriovenous Fistula Therapeutics, Global, Terminated Clinical Trials, 2015* 23
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Arteriovenous Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015* 30
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Proteon Therapeutics, Inc., 2015* 31
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by CYATHUS EXQUIRERE PharmaforschungsGmbH, 2015* 32
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Celladon Corporation, 2015* 33
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by California Institute of Renal Research, 2015* 34
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital Medical University, 2015* 35
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by City Hospitals Sunderland NHS Foundation Trust, 2015* 36
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 37
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 38
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2015* 39
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Englewood Hospital and Medical Center, 2015* 40
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Interventional Radiology in Oncology Study Group, 2015* 41
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cheng-Kung University Hospital, 2015* 42
Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Greater Glasgow and Clyde, 2015* 43

List of Figures
Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Arteriovenous Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Arteriovenous Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Arteriovenous Fistula Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11
Arteriovenous Fistula Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 14
Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 17
Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Arteriovenous Fistula Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Arteriovenous Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Arteriovenous Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
GlobalData Methodology 60

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.